Per Øyvind
Enger
Professor
Besøksadresse:
Jonas Lies vei 91
5009 Bergen
Postadresse:
Postboks 7804
5009 Bergen
Telefon:
+47 55 58 63 47
+47 55 58 63 73
E-post:
Tidsskriftartikler
- 2013. ACTIVATION OF THE PROTOTYPICAL SFK c-Src PROMOTES ANGIOGENESIS OF HUMAN GLIOBLASTOMA. Neuro-Oncology. 15: 3-3.
- 2013. COMBINED ANTI-ANGIOGENIC AND ANTI-INVASIVE TREATMENT OF ORTHOTOPICALLY ENGRAFTED HUMAN GBM XENOGRAFTS. Neuro-Oncology. 15: 43-43.
- 2013. Establishment of a novel dsRed NOD/Scid mouse strain to investigate the host and tumor cell compartments. Cancer Investigation. 31: 221-230. doi: 10.3109/07357907.2013.780075
- 2013. Elevated CD3(+) and CD8(+) tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level. Journal of Neuroimmunology. 264: 71-83. doi: 10.1016/j.jneuroim.2013.08.013
- 2013. Oct 7 IS EXPRESSED IN HUMAN GLIOMAS AND CORRELATES WITH MALIGNANCY GRADE. Neuro-Oncology. 15: 20-21.
- 2013. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival. OncoTarget. 4: 1527-1546.
- 2013. Gamma knife surgery of colorectal brain metastases: a high prescription dose of 25 Gy may improve growth control. World Neurosurgery. 79: 525-536. doi: 10.1016/j.wneu.2011.09.019
- 2013. Gamma knife surgery as monotherapy with clinically relevant doses prolongs survival in a Human GBM Xenograft Model. Biomedical research. 2013. 9 sider. doi: 10.1155/2013/139674
- 2013. Sulfasalazine sensitizes glioblastoma cells to radiation treatment. Neuro-Oncology. 15: 239-239.
- 2013. EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. Neuro-Oncology. 15: 6-6.
- 2013. EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. Acta Neuropathologica. 125: 683-698. doi: 10.1007/s00401-013-1101-1
- 2012. Early MRI findings of targeting the NG2 proteoglycan in GBM. The FASEB Journal. 26. 1 sider.
- 2012. HYPOXIA INDUCES CELL PROLIFERATION, EXPRESSION OF ANGIOGENIC FACTORS, AND PRIMITIVE NEURONAL MARKERS IN NORMAL GLIAL CELLS. Neuro-Oncology. 14: 11-11.
- 2012. Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation. BMC Cancer. 12. 10 sider. doi: 10.1186/1471-2407-12-21
- 2012. Gamma knife surgery versus reoperation for recurrent glioblastoma multiforme. World Neurosurgery. 78: 658-669. doi: 10.1016/j.wneu.2012.03.024
- 2012. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proceedings of the National Academy of Science of the United States of America. 109: 6662-6667. doi: 10.1073/pnas.1121623109
- 2011. Separate analysis of the cancer and stroma cell populations from orthotopically implanted tumor biopsies in eGFP scid mice. Clinical and Experimental Metastasis. 28: 203-203.
- 2011. Gamma Knife Surgery in Brain Melanomas: Absence of Extracranial Metastases and Tumor Volume Strongest Indicators of Prolonged Survival. World Neurosurgery. 75: 684-691. doi: 10.1016/j.wneu.2010.12.054
- 2011. Gamma Knife Surgery of Colorectal Brain Metastases: A High Prescription Dose of 25 Gy May Improve Growth Control. World Neurosurgery. 75: 684-691. doi: 10.1016/j.wneu.2010.12.054
- 2011. Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma. Acta Neuropathologica. 122: 495-510. doi: 10.1007/s00401-011-0867-2
- 2011. TUMOR-ASSOCIATED GLIAL CELLS PROMOTE GROWTH OF GBM XENOGRAFTS IN EGFP NOD/SCID MICE. Neuro-Oncology. 13: 55-55.
- 2011. Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma. PLoS ONE. 6. 14 sider. doi: 10.1371/journal.pone.0023062
- 2011. Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide. BMC Cancer. 20. doi: 10.1186/1471-2407-11-524
- 2010. NG2 PROMOTES RESISTANCE TO IONIZING RADIATION BY ELEVATED PEROXIREDOXIN-1 AND DNA DAMAGE RESPONSE IN GLIOBLASTOMA MULTIFORME. Neuro-Oncology. 12: 8-8.
- 2010. THERAPEUTIC TARGETING OF THE NG2 PROTEOGLYCAN WITH MAB 9.2.27 AND ADOPTIVELY TRANSFERRED NK CELLS LYSES HUMAN GLIOBLASTOMA MULTIFORME IN VIVO. Neuro-Oncology. 12: 9-9.
- 2010. Gamma knife surgery of meningiomas involving the cavernous sinus: long-term follow-up of 100 patients. Neurosurgery. 66: 661-669. doi: 10.1227/01.NEU.0000366112.04015.E2
- 2010. alpha B-Crystallin Is Elevated in Highly Infiltrative Apoptosis-Resistant Glioblastoma Cells. American Journal of Pathology. 177: 1618-1628. doi: 10.2353/ajpath.2010.090063
- 2010. Cancer stem cells in the central nervous system - a critical review. Cancer Research. 70: 8255-8258. doi: 10.1158/0008-5472.CAN-10-1592
- 2010. Glioma cell populations grouped by different cell type markers drive brain tumor growth. Cancer Research. 70: 4274-4279. doi: 10.1158/0008-5472.CAN-09-3904
- 2010. SULFASALAZINE SENSITIZES GLIOBLASTOMA CELLS TO RADIATION TREATMENT. Neuro-Oncology. 12: 109-109.
- 2009. Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype. Neuropathology and Applied Neurobiology. 35: 380-393. doi: 10.1111/j.1365-2990.2009.01008.x
- 2009. CD133-NEGATIVE GLIOMA SUBPOPULATIONS GROUPED BY DIFFERENT CELL TYPE MARKERS DISPLAY TUMORIGENICITY IN VIVO. Neuro-Oncology. 11: 917-917.
- 2009. PHENOTYPIC MODULATION OF EXPERIMENTAL GLIOMAS: PROGRESSION FROM GLIOMATOSIS CEREBRI-LIKE LESIONS TO GLIOBLASTOMA. Neuro-Oncology. 11: 897-897.
- 2009. A reproducible brain tumour model established from human glioblastoma biopsies. BMC Cancer. 9. doi: 10.1186/1471-2407-9-465
- 2009. Targeting the tumor stroma: a novel therapeutic strategy based on separate analysis of the malignant and stromal cell compartments in brain tumors. Neuro-Oncology. 11: 221-222.
- 2009. TARGETING THE TUMOR STROMA: A NOVEL THERAPEUTIC STRATEGY BASED ON SEPARATE ANALYSIS OF THE MALIGNANT AND STROMAL CELL COMPARTMENTS IN BRAIN TUMORS. Neuro-Oncology. 11: 965-965.
- 2008. The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. Oncogene. 27: 5182-5194. doi: 10.1038/onc.2008.157
- 2008. Human glioblastoma tissue engraftment in immunocompetent rodent hosts. Neuro-Oncology. 10: 815-815. doi: 10.1215/15228517-2008-051
- 2008. COMPLETE SEPARATION AND PHENOTYPING OF THE TUMOR-HOST CELLULAR COMPARTMENTS IN TUMOR-BEARING NOD/SCID MICE. Neuro-Oncology. 10: 853-854.
- 2008. Complete separation and phenotyping of the tumor-host cellular compartments in tumor bearing nod/scid mice. Neuro-Oncology. 10: 1148-1148.
- 2008. A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions. The FASEB Journal. 22: 3120-3128. doi: 10.1096/fj.08-109611
- 2008. CD133-NEGATIVE GLIOMA SUBPOPULATIONS GROUPED BY DIFFERENT CELL TYPE MARKERS DISPLAY TUMORGENICITY IN VIVO. Neuro-Oncology. 10: 778-778.
- 2008. Two distinct tumor phenotypes isolated from glioblastomas show different MRS characteristics. NMR in Biomedicine. 21: 830-838. Publisert 2008-10-21. doi: 10.1002/nbm.1263
- 2008. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. International Journal of Cancer. 122: 761-768. doi: 10.1002/ijc.23130
- 2007. Lymphangiogenesis in colorectal cancer - Prognostic and therapeutic aspects. International Journal of Cancer. 121: 1401-1409. doi: 10.1002/ijc.22996
- 2007. Human glioblastoma biopsy spheroids xenografted into the nude rat brain show growth inhibition after stereotactic radiosurgery. Journal of Neuro-Oncology. 82: 1-10. doi: 10.1007/s11060-006-9240-z
- 2006. NG2 expression regulates vascular morphology and function in human brain tumours. NeuroImage. 29: 965-976. doi: Se sammendrag
- 2006. Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. Cancer Research. 66: 9895-9902. doi: 10.1158/0008-5472.CAN-05-4589
- 2006. Antitumor efficacy improved by local delivery of species-specific endostatin. Journal of Neurosurgery. 104: 118-128.
- 2006. Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proceedings of the National Academy of Science of the United States of America. 103: 16466-16471. doi: 10.1073/pnas.0607668103
- 2006. Primary glioma spheroids maintain tumourogenicity and essential phenotypic traits after cryopreservation. Neuropathology and Applied Neurobiology. 32: 419-427. doi: 10.1111/j.1365-2990.2006.00744.x
- 2005. NG2 expression regulates vascular morphology and function in human brain tumours. NeuroImage. 29: 965-976. Publisert 2005-10-25. doi: 10.1016/j.neuroimage.2005.08.0
- 2004. Angiogenesis-independent growth by brain tumor cells exhibiting cancer stem cell properties. Neuro-Oncology. 6: 309-309.
- 2004. Forced differentiation suppresses the proliferative rate of cancer cells in brain tumours. Neuro-Oncology. 6.
- 2002. NG2 proteoglycan promotes angiogenesis-dependent tumor growth in the central nervous system by sequestering angiostatin. The FASEB Journal. 16: 586-588.
- 2001. Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nature Biotechnology. 19: 29-34.
Rapporter/avhandlinger
- 2011. Impact of hypoxia on the expression of cell line markers and behavior of cultured glioma cell lines. Institutt for biomedisin, Universitetet i Bergen.
- 2011. GROWTH OF GLIOBLASTOMA XENOGRAFTS IN THE BRAINS OF NOD/SCID MICE FOLLOWING ADMINISTRATION OF A DEMYELINATING AGENT. Institutt for biomedisin, Universitetet i Bergen.
